Get the Stockscreener App
2.13
8.67%
0.17
Pre-market:
2.13
Cardiff Oncology Inc stock is traded at $2.13, with a volume of 1.45M.
It is up +8.67% in the last 24 hours and down -15.14% over the past month.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
See More
Previous Close:
$1.96
Open:
$1.97
24h Volume:
1.45M
Relative Volume:
0.79
Market Cap:
$141.70M
Revenue:
$488.00K
Net Income/Loss:
$-41.44M
P/E Ratio:
-2.2903
EPS:
-0.93
Net Cash Flow:
$-31.47M
1W Performance:
+2.40%
1M Performance:
-15.14%
6M Performance:
-42.97%
1Y Performance:
-2.74%
1-Day Range:
$1.96
$2.15
1-Week Range:
$1.90
$2.15
52-Week Range:
$1.90
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
Name
Cardiff Oncology Inc
Sector
Industry
Phone
858-952-7570
Address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Compare CRDF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
2.13 | 129.73M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Initiated | Ladenburg Thalmann | Buy |
| Jun-24-25 | Initiated | Jefferies | Hold |
| Sep-06-24 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | William Blair | Outperform |
| Dec-08-21 | Initiated | Robert W. Baird | Outperform |
| Aug-09-21 | Resumed | Maxim Group | Buy |
| Oct-22-20 | Initiated | H.C. Wainwright | Buy |
| Oct-08-20 | Initiated | Piper Sandler | Overweight |
View All
Cardiff Oncology Inc Stock (CRDF) Latest News
Will Cardiff Oncology Inc. rebound enough to break even2025 Geopolitical Influence & Intraday High Probability Alerts - Newser
Is Cardiff Oncology Inc. a momentum stockTrade Ideas & Technical Buy Zone Confirmations - 강소기업뉴스
Is Cardiff Oncology Inc. trending in predictive chart modelsJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
Best data tools to analyze Cardiff Oncology Inc. stockIPO Watch & Advanced Swing Trade Entry Plans - Newser
Is now a turning point for Cardiff Oncology Inc.July 2025 Highlights & Technical Entry and Exit Alerts - Newser
Will Cardiff Oncology Inc. price bounce be sustainableEarnings Recap Summary & High Conviction Buy Zone Alerts - Newser
Has Cardiff Oncology Inc. formed a bullish divergence2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
Does Cardiff Oncology Inc. qualify in momentum factor screening2025 Short Interest & Comprehensive Market Scan Insights - Newser
Will Cardiff Oncology Inc. benefit from rising consumer demandWeekly Gains Report & Expert-Curated Trade Recommendations - khodrobank.com
What high frequency data says about Cardiff Oncology Inc.Earnings Overview Report & Weekly Breakout Watchlists - Newser
What institutional flow reveals about Cardiff Oncology Inc.Weekly Investment Report & Safe Entry Point Identification - Newser
Published on: 2025-09-04 00:32:22 - Newser
Should I average down on Cardiff Oncology Inc. stockDividend Hike & Trade Opportunity Analysis - khodrobank.com
What Fibonacci levels say about Cardiff Oncology Inc. reboundBreakout Watch & Verified High Yield Trade Plans - Newser
How moving averages guide Cardiff Oncology Inc. trading2025 Fundamental Recap & Precise Trade Entry Recommendations - Newser
Regression analysis insights on Cardiff Oncology Inc. performanceTrade Volume Summary & Daily Stock Trend Watchlist - Newser
What moving averages say about Cardiff Oncology Inc.2025 Historical Comparison & AI Based Buy and Sell Signals - Newser
Will a bounce in Cardiff Oncology Inc. offer an exitRisk Management & Daily Profit Maximizing Tips - Newser
Published on: 2025-09-03 14:37:09 - khodrobank.com
Using data filters to optimize entry into Cardiff Oncology Inc.Quarterly Earnings Summary & High Yield Equity Trading Tips - Newser
Is Cardiff Oncology Inc. a play on infrastructure spending2025 Market WrapUp & Risk Controlled Swing Alerts - khodrobank.com
Signal strength of Cardiff Oncology Inc. stock in tech scannersWeekly Stock Report & Consistent Return Investment Signals - Newser
What is Cardiff Oncology Inc. s 5 year growth outlook2025 Bull vs Bear & Real-Time Price Movement Reports - khodrobank.com
What to do if you’re stuck in Cardiff Oncology Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - Newser
How to build a custom watchlist for Cardiff Oncology Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - Newser
Is Cardiff Oncology Inc. building a consolidation baseJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Is Cardiff Oncology Inc. stock a growth or value playJuly 2025 Technicals & Real-Time Volume Analysis Alerts - Newser
Published on: 2025-09-02 00:18:09 - Newser
Is Cardiff Oncology Inc. stock poised for growthPortfolio Performance Summary & Expert Verified Movement Alerts - Newser
Will Cardiff Oncology Inc. benefit from current market trendsWeekly Profit Recap & Free Growth Oriented Trading Recommendations - khodrobank.com
Can Cardiff Oncology Inc. weather a recessionForecast Cut & AI Optimized Trading Strategy Guides - khodrobank.com
Forecasting Cardiff Oncology Inc. price range with options dataInsider Selling & Community Consensus Trade Alerts - Newser
Long term hold vs stop loss in Cardiff Oncology Inc.July 2025 Summary & Precise Trade Entry Recommendations - Newser
How Cardiff Oncology Inc. stock performs during market volatility2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Cardiff Oncology Inc. Price Holds Above Key Fib Level getLinesFromResByArray error: size == 0 - thegnnews.com
Can Cardiff Oncology Inc. recover in the next quarterJuly 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Cardiff Oncology Inc Stock (CRDF) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cardiff Oncology Inc Stock (CRDF) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PACE GARY W | Director |
Jul 30 '25 |
Buy |
2.45 |
15,000 |
36,750 |
1,345,676 |
| Levine James E. | Chief Financial Officer |
Dec 17 '24 |
Buy |
5.42 |
2,752 |
14,905 |
65,316 |
| Levine James E. | Chief Financial Officer |
Dec 18 '24 |
Buy |
5.00 |
2,400 |
12,000 |
67,716 |
| Levine James E. | Chief Financial Officer |
Dec 16 '24 |
Buy |
3.83 |
2,564 |
9,820 |
62,564 |
| TANNENBAUM RENEE P | Director |
Dec 12 '24 |
Buy |
3.42 |
10,000 |
34,224 |
20,000 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
350,115 |
910,299 |
1,047,876 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
11,500 |
29,900 |
1,059,376 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):